Filing Details
- Accession Number:
- 0001178913-22-001120
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-15 16:10:10
- Reporting Period:
- 2022-03-14
- Accepted Time:
- 2022-03-15 16:10:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1534248 | Chemomab Therapeutics Ltd. | CMMB | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1394663 | R Dale Pfost | 1316 Jefferson Ave New Orleans LA 70115 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
American Depositary Shares | Acquisiton | 2022-03-14 | 1,800 | $3.98 | 1,800 | No | 4 | P | Direct | |
American Depositary Shares | Acquisiton | 2022-03-14 | 700 | $3.97 | 2,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
American Depositary Shares | Option to Purchase American Depositary Shares | Acquisiton | 2021-10-25 | 459,353 | $0.00 | 459,353 | $10.05 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
459,353 | 2031-10-25 | No | 4 | A | Direct |
Footnotes
- Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
- No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- The options vest and become exercisable over a period of four (4) years with one quarter (1/4) of the options vesting on October 25, 2022 -- the first anniversary of the grant date -- and the remainder in equal amounts over the ensuing 36 monthly periods, subject to the Reporting Person's continued service.